About AXXIUM LIFE, INC
Axxium is a biotechnology company focused on developing AI-powered active immunotherapies (AIM) for chronic diseases, including Alzheimer's and Parkinson's. The company has been de-risking its AIM technology for 20 years and has achieved significant clinical and preclinical milestones.
Development of AI-powered active immunotherapies (AIM) for chronic diseasesHigh-precision drug design targeting personalized antibodiesPreclinical and clinical trial execution with over 4,200 participants dosedProprietary AI platform h.a.l. for drug discovery and developmentPublication in leading scientific journals such as Nature Medicine, Lancet BioMedicine, and Nature Communications Medicine
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to AXXIUM LIFE, INC right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.